Aniela Nodiţi, Benjamin Sarfati, Teodora-Mihaela Peleaşă, Smaranda Stoleru, Mihaela Alexandra Radu, Cătălin Copăescu, Alexandru Blidaru
{"title":"The First Romanian Robotic-Assisted Mastectomy: A Starting Point for a Literature Review.","authors":"Aniela Nodiţi, Benjamin Sarfati, Teodora-Mihaela Peleaşă, Smaranda Stoleru, Mihaela Alexandra Radu, Cătălin Copăescu, Alexandru Blidaru","doi":"10.21614/chirurgia.3061","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> The advancements in the field of robotic surgery have led to its use in breast surgery. We report the first robotic-assisted nipple-sparing mastectomy (RNSM) using the da Vinci Xi surgical system, in Romania, for a patient with contralateral breast cancer. Immediate breast reconstruction was performed using a silicone implant. There were no major immediate complications. On this occasion, a systematic review was performed to examine the data on safety, feasibility, oncological and cosmetic outcomes for this procedure.\n<b>Methods:</b> We reviewed the literature from September 2015 to August 2024 in PubMed, Scopus, and EMBASE. Original studies reporting on patients diagnosed with or at high-risk of breast cancer undergoing RNSM were included.\n<b>Results:</b> Postoperative complications of RNMS were minimal and comparable to those observed with conventional nipple-sparing mastectomy. Furthermore, two studies found that RNSM resulted in significantly lower rates of skin and nipple-areola complex necrosis compared to open surgery (0% vs. 12.5% and 2.4% vs. 15.2%, respectively). Additionally, robotic-assisted mastectomy was linked to greater overall cosmetic satisfaction. On the other hand, the total costs and operating times for robotic procedures were higher than those for open surgery.\n<b>Conclusion:</b> RNSM is a feasible technique for prophylactic purposes, with both advantages and disadvantages. Although emerging data support the oncological safety and potential benefits, future studies are needed to validate its efficacy in cancer treatment.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"119 5","pages":"600-604"},"PeriodicalIF":0.8000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chirurgia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21614/chirurgia.3061","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The advancements in the field of robotic surgery have led to its use in breast surgery. We report the first robotic-assisted nipple-sparing mastectomy (RNSM) using the da Vinci Xi surgical system, in Romania, for a patient with contralateral breast cancer. Immediate breast reconstruction was performed using a silicone implant. There were no major immediate complications. On this occasion, a systematic review was performed to examine the data on safety, feasibility, oncological and cosmetic outcomes for this procedure.
Methods: We reviewed the literature from September 2015 to August 2024 in PubMed, Scopus, and EMBASE. Original studies reporting on patients diagnosed with or at high-risk of breast cancer undergoing RNSM were included.
Results: Postoperative complications of RNMS were minimal and comparable to those observed with conventional nipple-sparing mastectomy. Furthermore, two studies found that RNSM resulted in significantly lower rates of skin and nipple-areola complex necrosis compared to open surgery (0% vs. 12.5% and 2.4% vs. 15.2%, respectively). Additionally, robotic-assisted mastectomy was linked to greater overall cosmetic satisfaction. On the other hand, the total costs and operating times for robotic procedures were higher than those for open surgery.
Conclusion: RNSM is a feasible technique for prophylactic purposes, with both advantages and disadvantages. Although emerging data support the oncological safety and potential benefits, future studies are needed to validate its efficacy in cancer treatment.
期刊介绍:
Chirurgia is a bimonthly journal. In Chirurgia, original papers in the area of general surgery which neither
appeared, nor were sent for publication in other periodicals, can be published. You can send original articles,
new surgical techniques, or comprehensive general reports on surgical topics, clinical case presentations and,
depending on publication space, - reviews of some articles of general interest to surgeons from other publications.
Chirurgia is also a place for sharing information about the activity of various branches of the Romanian Society of
Surgery, information on Congresses and Symposiums organized by the Romanian Society of Surgery and
participation notes in other scientific meetings.
Letters to the editor: Letters commenting on papers published in Chirurgia are welcomed. They should contain
substantive ideas and commentaries supported by appropriate data, and should not exceed 2 pages. Please
submit these letters to the editor through our online system.